C. Scatena, R. Ravasio, P. Raimondo, and M. Giuliano, “A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel”, FE, vol. 22, no. 1, Jul. 2021.